Article Text

Download PDFPDF
Acquired rippling muscle disease in association with myasthenia gravis
  1. J S George1,
  2. S Harikrishnan1,
  3. I Ali1,
  4. R Baresi2,
  5. C O Hanemann3
  1. 1
    Derriford Hospital, Plymouth Hospitals NHS Trust, Derriford, Plymouth, UK
  2. 2
    NCG Diagnostic and Advisory Service for Rare Neuromuscular Diseases, Muscle Immunoanalysis Unit, Dental Hospital, Newcastle upon Tyne, UK
  3. 3
    Peninsula College for Medicine and Dentistry, Department of Clinical Neurobiology, Institute of Biomedical and Clinical Science, Peninsula Medical School, Plymouth, UK
  1. Correspondence to Professor C O Hanemann, Department of Clinical Neurobiology, Peninsula Medical School, The John Bull Building, Tamar Science Park, Research Way, Plymouth PL6 8BU, UK; Oliver.Hanemann{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We present a case of acquired rippling muscle disease associated with myasthenia gravis and a unique combination of physical signs and muscle biopsy findings.

Rippling muscle disease (RMD) is a rare and generally benign myopathy characterised by muscle stiffness, muscle hypertrophy and self-propagating rippling of muscles induced by stretch or percussion.1 Myoedema, percussion induced rapid contraction and 3–25- fold elevation of serum creatine kinase (CK) levels are also typical features.

RMD occurs in genetic and sporadic forms. The autosomal dominant genetic form includes two distinct loci: the caveolin-3 gene and an undefined locus at 1q41–q42.2 Caveolin-3 gene mutations are also seen in patients with limb girdle muscular dystrophy 1C, distal myopathy and idiopathic hyperCKaemia. An autosomal recessive form also exists.3 Sporadic RMD is thought to be immune mediated.4 5 6 There are four case reports of acquired RMD in association with myasthenia gravis (RMD-MG) (ie, eight patients in total with RMD-MG since the first reported case in 1996).4 5 6 7 We …

View Full Text


  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and Peer review Not commissioned; externally peer reviewed.